University of Bristol spinout Albotherm lands £1.6m investment
University of Bristol spin-out Albotherm, whose innovative carbon-saving coating for commercial greenhouses could boost food production by a third, has secured a £1.6 million investment.
Axol Bioscience collaborates with StrataStem to deliver stem cell based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease
Together, an extensive panel of consented patient samples and iPSC technology will advance AD drug development and patient stratification.
University spin-out secures £500k from angels
Molymem is working with the Graphene Engineering Innovation Centre and will scale its technology platform and build its team
Computing platform developer Signaloid raises £3 million in a seed round led by IQ Capital
Signaloid's platform enables automatic tracking of real-world data variations, offering faster computation and risk reduction
Sphere Fluidics updates brand identity to align with ambitious, global commercial growth strategy
Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, today announced the introduction of new branding to align with its ambitious global commercial growth strategy. The update has been introduced to better reflect the Company’s customer-centric approach and showcase its pioneering single cell discovery and analysis technology, following a period of significant growth and program success.
FocalPoint founder stresses the power of IP for any technology trailblazer
Cambridge-based DeepTech scale-up FocalPoint, which is on a mission to be in every single GPS chip on the planet, says its Supercorrelation™ technology is currently licensed to Swiss influencer u-blox among several international businesses and is in advanced trials with several major device manufacturers.
PharmEnable closes $7.5m funding round to scale drug hunt
PharmEnable, a Cambridge drug discovery company focused on chemical novelty, diversity and complexity, has closed a Pre-Series A investment round of $7.5 million to develop the next generation of small molecule drugs against disease areas of high clinical need.
Partners to use AI on clinical trial data to help advance care, therapies
Collaborators hope to discover prognostic markers for IPF, other ILDs
Closed Loop Medicine and Pharmanovia enter a co-development partnership for precision medicine combination therapeutics
Closed Loop Medicine Ltd, a leading TechBio company, developing combination prescription drug plus software therapy products that enable personalized dose optimization, and Pharmanovia, a global pharmaceutical company that commercializes novel medicines and revitalizes, extends and expands the lifecycle of established medicines, today announced that they have entered a global co-development partnership.
SSTL + Oxford Space Systems to launch the CarbSAR in orbit demo mission to showcase wrapped rib antenna
Surrey Satellite Technology Ltd. (SSTL) and Oxford Space Systems (OSS) have confirmed a partnership to build and launch an OSS Wrapped Rib antenna mounted to an SSTL CarbSAR satellite.
Funderbeam lands £31.7m for investor marketplace
Irish venture capital firm VentureWave has led a $40m (£31.7m) round into the investment site Funderbeam.
MicrofluidX and Immatics working together on automated end-to-end bioprocessing for TCR-T therapies
Joint research project with the goal of increasing efficiency and reducing cost of manufacture through precision process control
Paragraf’s California acquisition brings new electronics frontier ever closer
Graphene technology pathfinder Paragraf, which is expanding fast on both sides of the Atlantic, has strengthened still further with a key acquisition in San Diego.
Ken Hitchner Appointed as Board of Directors Chairman
Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has appointed Kenneth Hitchner BA MBA as Chairman of its Board of Directors. The announcement follows a series of appointments to the Company’s senior leadership team, as part of its ambitious global growth strategy.
Arecor celebrates US antibodies patent
Cambridge biopharma company Arecor Therapeutics has won a key patent approval in the US.
Rovco launches site characterisation business
Line will help to address an industry shortfall of companies with all-round skills to do site consenting surveys
UK-Based CyberSmart Makes Waves in SME Cybersecurity Market
CyberSmart, the category leader in simple and accessible automated cybersecurity technology for small and medium sized enterprises (SMEs), has today announced a record year of growth, marked by a large funding round, headcount and customer growth as well as geographical market expansion.
Ex-Dyson ace hoovered up by Featurespace as new CFO
Former Dyson financial wizard John Shipsey has been named as new chief financial officer of globally scaling Cambridge tech company Featurespace.
NatWest Improves Scam Detection Rate By 135% using Featurespace’s Technology
New findings today from Featurespace, the world leader in machine learning fraud and financial crime prevention technology, highlights that its innovative modelling technology has helped NatWest to improve its financial scam detection rate by 135%.
Sphere Fluidics in €3.4m cancer campaign
Cambridge life science company Sphere Fluidics is part of a consortium awarded €3.4 million for an important new cancer research programme.